Literature DB >> 32459433

Perioperative Use of Cefazolin and Indomethacin for Physical Examination-Indicated Cerclages to Improve Gestational Latency.

Ashish Premkumar1, Nikita Sinha, Emily S Miller, Alan M Peaceman.   

Abstract

OBJECTIVE: To evaluate gestational latency in individuals who did and did not receive perioperative cefazolin and indomethacin after physical examination-indicated cerclage.
METHODS: This is a retrospective cohort study of all pregnant women with a singleton gestation who underwent physical examination-indicated cerclage placement and delivered at Northwestern Memorial Hospital from 2009 to 2018. Physical examination-indicated cerclage was performed in the setting of painless cervical dilation of at least 1 cm between 16 0/7 and 23 6/7 weeks of gestation. After 2014, our practice universally implemented perioperative prophylaxis of cefazolin and indomethacin. Individuals were categorized based on exposure to perioperative prophylaxis. The primary outcome was pregnancy latency at least 28 days after cerclage placement. Secondary outcomes included median latency; median gestational age at delivery; preterm birth before 28 weeks of gestation; preterm prelabor rupture of membranes; chorioamnionitis; and median birth weight. Multivariable analyses were performed, as well as a sensitivity analysis using propensity score matching.
RESULTS: Cerclages were placed in 142 people: 72 (50.7%) received perioperative prophylaxis. Baseline demographics were not significantly different between groups. On multivariable analyses, individuals who received perioperative prophylaxis had a higher incidence of achieving a pregnancy latency at 28 days or more (adjusted relative risk [aRR] 1.21, 95% CI 1.05-1.40). Individuals who received perioperative prophylaxis had a significant improvement in gestational latency (+17.8 days, 95% CI 1.4-34.2 days) and birth weight (+489.8 g, 95% CI 64.6-915.0 g), with no differences in other outcomes. On sensitivity analysis, individuals receiving perioperative prophylaxis had a higher incidence of achieving a pregnancy latency at 28 days or more, (aRR 1.17, 95% CI 1.01-1.36) with no differences in other outcomes.
CONCLUSION: Perioperative use of cefazolin and indomethacin prophylaxis during physical examination-indicated cerclage placement is associated with a significant prolongation in gestational latency without an increase in incidence of chorioamnionitis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32459433      PMCID: PMC7291850          DOI: 10.1097/AOG.0000000000003874

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  23 in total

1.  Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop.

Authors:  Rosemary D Higgins; George Saade; Richard A Polin; William A Grobman; Irina A Buhimschi; Kristi Watterberg; Robert M Silver; Tonse N K Raju
Journal:  Obstet Gynecol       Date:  2016-03       Impact factor: 7.661

2.  Prostaglandin F1a and prostaglandin E2 plasma levels after transvaginal cervical cerclage.

Authors:  N Vitoratos; D Hassiakos; C Louridas; G Limuris; P A Zourlas
Journal:  Clin Exp Obstet Gynecol       Date:  1996       Impact factor: 0.146

3.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

4.  Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone.

Authors:  S M Althuisius; G A Dekker; P Hummel; D J Bekedam; H P van Geijn
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

5.  ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency.

Authors: 
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

6.  Plasma concentrations of prostaglandin F2 alpha and prostaglandin E2 metabolites after transabdominal and transvaginal cervical cerclage.

Authors:  M J Novy; C A Ducsay; F Z Stanczyk
Journal:  Am J Obstet Gynecol       Date:  1987-06       Impact factor: 8.661

7.  A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trimester preterm dilatation of the internal os.

Authors:  O A Rust; R O Atlas; K J Jones; B N Benham; J Balducci
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

8.  Methods for constructing and assessing propensity scores.

Authors:  Melissa M Garrido; Amy S Kelley; Julia Paris; Katherine Roza; Diane E Meier; R Sean Morrison; Melissa D Aldridge
Journal:  Health Serv Res       Date:  2014-04-30       Impact factor: 3.402

9.  The effect of cervical encerclage on plasma prostaglandin concentrations during early human pregnancy.

Authors:  J G Bibby; J Brunt; M D Mitchell; A B Anderson; A C Turnbull
Journal:  Br J Obstet Gynaecol       Date:  1979-01

10.  Plasma prostaglandin concentrations after cerclage in early pregnancy.

Authors:  P J Toplis; J H Shepherd; E Youssefmejadian; D Jakubowicz; J Dewhurst
Journal:  Br J Obstet Gynaecol       Date:  1980-08
View more
  1 in total

1.  Prognosis and Prognostic Factors of Patients with Emergent Cerclage: A Japanese Single-Center Study.

Authors:  Ami Kobayashi; Hironori Takahashi; Shigeki Matsubara; Yosuke Baba; Shiho Nagayama; Manabu Ogoyama; Kenji Horie; Hirotada Suzuki; Rie Usui; Akihide Ohkuchi; Hiroyuki Fujiwara
Journal:  Obstet Gynecol Int       Date:  2021-12-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.